BR0307733A - Derivados de fenalenona, processo para sua preparação e seu uso - Google Patents

Derivados de fenalenona, processo para sua preparação e seu uso

Info

Publication number
BR0307733A
BR0307733A BR0307733-0A BR0307733A BR0307733A BR 0307733 A BR0307733 A BR 0307733A BR 0307733 A BR0307733 A BR 0307733A BR 0307733 A BR0307733 A BR 0307733A
Authority
BR
Brazil
Prior art keywords
preparation
phenalenone
derivatives
phenalenone derivatives
fermentation
Prior art date
Application number
BR0307733-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Laszlo Vertesy
Michael Kurz
Ziyu Li
Luigi Toti
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of BR0307733A publication Critical patent/BR0307733A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92—Naphthofurans; Hydrogenated naphthofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/80—Penicillium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BR0307733-0A 2002-02-18 2003-02-04 Derivados de fenalenona, processo para sua preparação e seu uso BR0307733A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10206849A DE10206849A1 (de) 2002-02-18 2002-02-18 Phenalenon-Derivate, Verfahren zur Herstellung und Verwendung derselben
PCT/EP2003/001060 WO2003068946A1 (de) 2002-02-18 2003-02-04 Phenalenon-derivative, verfahren zur herstellung und verwendung derselben

Publications (1)

Publication Number Publication Date
BR0307733A true BR0307733A (pt) 2005-01-25

Family

ID=27674733

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307733-0A BR0307733A (pt) 2002-02-18 2003-02-04 Derivados de fenalenona, processo para sua preparação e seu uso

Country Status (10)

Country Link
EP (1) EP1478731A1 (https=)
JP (1) JP2005517710A (https=)
AR (1) AR038524A1 (https=)
AU (1) AU2003210205B2 (https=)
BR (1) BR0307733A (https=)
CA (1) CA2476618A1 (https=)
DE (1) DE10206849A1 (https=)
MX (1) MXPA04007918A (https=)
PE (1) PE20030904A1 (https=)
WO (1) WO2003068946A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010113725A1 (ja) * 2009-03-30 2010-10-07 日本水産株式会社 三環性縮合複素環化合物、その製造方法および用途
WO2011009899A2 (en) * 2009-07-22 2011-01-27 Instituto Biomar, S.A. Phenalenones as antitumoral agents
FR2987622B1 (fr) * 2012-03-02 2016-01-15 Centre Nat Rech Scient Composes oxo-phenalenes, leur preparation et utilisation dans les domaines des materiaux et therapeutique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2812510B2 (ja) * 1989-10-06 1998-10-22 日清製油株式会社 アトロベネチンの用途
EP1151295A4 (en) * 1999-02-01 2005-03-30 Cytovia Inc METHOD FOR IDENTIFYING THERAPEUTICALLY EFFECTIVE ANTINEOPLASTIC SUBSTANCES USING CULTURED CELLS WITH INTACT CELL MEMBRANES AND RELATED PRODUCTS THEREOF

Also Published As

Publication number Publication date
MXPA04007918A (es) 2004-11-26
AR038524A1 (es) 2005-01-19
JP2005517710A (ja) 2005-06-16
AU2003210205B2 (en) 2007-06-14
PE20030904A1 (es) 2003-11-18
CA2476618A1 (en) 2003-08-21
DE10206849A1 (de) 2005-07-28
AU2003210205A1 (en) 2003-09-04
WO2003068946A1 (de) 2003-08-21
EP1478731A1 (de) 2004-11-24

Similar Documents

Publication Publication Date Title
US6355692B2 (en) Method of inhibiting formation of infectious microorganisms
BRPI0409716A (pt) derivados de 2-acilamino-4-feniltiazol, seu preparo e sua aplicação em terapêutica
BRPI0210941B8 (pt) produto farmacêutico contendo combinações de oxazolidinonas substituídas, seu uso, seu processo de produção, e medicamento
BG103945A (bg) Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а
BRPI0410029B8 (pt) composto dihidroquinazolina substituído, processo para sua preparação, medicamento compreendendo o referido composto e uso do referido composto
CY1111061T1 (el) Νεες ετεροκυκλικες ενωσεις δραστικες ως αναστολεις των βητα-λακταμασων
NZ527123A (en) Oxazolyl-pyrazole derivatives as kinase inhibitors
BR0013281A (pt) Derivados de arilmetil-carbonilamino-tiazol, processo para sua preparação e seu uso como agentes antitumorais
BR122019010200B8 (pt) compostos de pirazol-quinazolina, seus sais, produtos ou kits e composições farmacêuticas
PT1274698E (pt) Perciquinina, metodo para a sua producao e sua utilizacao como medicamento
BR0314314A (pt) Derivados do éter 4-pirrolidina-fenil-benzìlico
GEP20094725B (en) Process for production of optically active amine derivatives
EP1594885B8 (de) Medikament zur wachstumsinhibierung von tumoren
YU13699A (sh) Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože
DE69417920D1 (de) VERWENDUNG VOR EINFACHERN ODER CONJUGIERTEM DEXTRAN zur Herstellung eines Medikaments ZUR VORBEUGUNG ODER VERMINDERUNG DES RISIKOS EINER BACTERIELLER PATHOGENER INFEKTION
DK0405116T5 (da) Phenylalkan- og phenylalkensyrer
PL360492A1 (en) Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
ATE510845T1 (de) Antibakterielle makrozyklen mit substituiertem biphenyl
BR0307733A (pt) Derivados de fenalenona, processo para sua preparação e seu uso
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
SE0402507D0 (sv) Medicinsk lösning, förfarande för framställning och användning därav
BRPI0415978A (pt) derivados de 2-fenil-benzofurano, processos para a sua produção e seu uso
BR0010525A (pt) cido 1-ciclo-hexeno-1-carboxìlico e 1-ciclo-hexeno-1carboxilatos como inibidores de neuraminidase
BR112023027454A2 (pt) Composto, uso de um composto, medicamento, e, invenção de produto, processo, sistema, kit ou uso

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE)

Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH

B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE 6A., E 7A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010.